We are looking for young people 2 to 17 years of age to join a CD medical research study to help us discover more about treating moderate to severe IBD. If you are looking for a potential new treatment option for moderate to severe IBD or IBD (including associated symptoms such as rectal pain, failure to thrive, bloody stool, frequent fevers and/or eye pain), consider one of our trials. All eligible participants will receive no-cost study-related care and study medication. Your young people 2 to 17 years of age may be eligible to take part.
Your child may be eligible to take part in the trials if they:
- are 2‒17 years of age
- have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
- have previously received treatment for UC or CD that has not worked.
Enrollment is limited so act quickly.
